Checkpoint Inhibitor-Induced Enterocolitis
When the immune system attacks the lining of the bowel/intestines as a result of checkpoint inhibitor therapy, the condition is called checkpoint inhibitor-induced enterocolitis, or ICI-induced enterocolitis.
Checkpoint inhibitor therapy is a type of cancer treatment which involves activating the immune system in order to locate and attack cancer cells more effectively. However, though checkpoint inhibitor therapy can be effective to treat cancer, it can also cause adverse immune-related side effects, including autoimmune reactions to other, healthy parts of the body.